InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,219.58
(
-0.06%
)
US TECH 100
17,715.60
(
0.19%
)
Dow Jones
39,441.19
(
-0.18%
)
Brent Oil
83.01
(
0.76%
)
Bitcoin
62,692.01
(
2.01%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Stock Trading Guru

Send PM Follow Ignore
Followers 14
Posts 119
Boards Moderated 1
Alias Born 01/14/2015

Stock Trading Guru

Re: None

Thursday, 01/29/2015 12:28:54 AM

Thursday, January 29, 2015 12:28:54 AM

Post# of 80490
Average price target of $7.40 by analysts = Brokerages Set Ariad Pharmaceuticals Price Target at $7.40
Rumors that bigger firms like Eli Lilly are willing to pay up to $20 a share for the stock = Ariad attracts attention of Eli Lilly, GlaxoSmithKline and Shire

That's pretty awesome hype. Whether you believe it all or not, it's still awesome hype that you got to appreciate. Here's the problem: dangerous market right now. If market continues to go lower over next few days, may get a better entry price after today's (January 28, 2015) long upper shadow gravestone doji. Be careful but yeah, I get the gambit on this one.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up